• 제목/요약/키워드: Esophageal Cancer

검색결과 600건 처리시간 0.03초

Selection and optimization of nutritional risk screening tools for esophageal cancer patients in China

  • Dong, Wen;Liu, Xiguang;Zhu, Shunfang;Lu, Di;Cai, Kaican;Cai, Ruijun;Li, Qing;Zeng, Jingjing;Li, Mei
    • Nutrition Research and Practice
    • /
    • 제14권1호
    • /
    • pp.20-24
    • /
    • 2020
  • BACKGROUND/OBJECTIVES: Malnutrition has multiple impacts on surgical success, postoperative complications, duration of hospital stay, and costs, particularly for cancer patients. There are various nutrition risk screening tools available for clinical use. Herein, we aim to determine the most appropriate nutritional risk screening system for esophageal cancer (EC) patients in China. SUBJECTS/METHODS: In total, 138 EC patients were enrolled in this study and evaluated by experienced nurses using three different nutritional screening tools, the Nutrition Risk Screening 2002 tool (NRS2002), the Patient-generated Subjective Globe Assessment (PG-SGA), and the Nutrition Risk Index (NRI).We compared sensitivity, specificity, positive and negative likelihood ratios, and Youden index generated by each of the three screening tools. Finally, cut-off points for all three tools were re-defined to optimize and validate the best nutritional risk screening tool for assessing EC patients. RESULTS: Our data suggested that all three screening tools were 100% sensitive for EC patients, while the specificities were 44.4%, 2.96%, and 59.26% for NRS 2002, PG-SGA, and NRI, respectively. NRI had a higher positive likelihood ratio as well as a higher area under the receiver operating characteristic curve compared to those of NRS 2002 and PG-SGA; although, all three tools had null negative likelihood ratios. After adjusting the cut-off points, the specificity and accuracy for all tools were significantly improved, however, the NRI remained the most appropriate nutritional risk screening system for EC patients. CONCLUSIONS: The NRI is the most suitable (highest sensitivity and accuracy) nutritional risk screening tool for EC patients. The performance of the NRI can be significantly improved if the cut-off point is modified according to the results obtained using MedCalc software.

위분문부 및 식도암 환자에서 경열공 식도절제술 (Transhiatal Esophagectomy in Cardia and Esophageal Cancer)

  • 최동휘;정경원;김동헌
    • Journal of Gastric Cancer
    • /
    • 제5권1호
    • /
    • pp.1-9
    • /
    • 2005
  • 목적: 현재 위분문부 및 식도암에 대한 근분 치로 원칙은 수술적 치료이며, 이에 대한 방법으로는 기존에는 주로 개흉을 요하는 McKeown술식(transthoracic esophagectomy, TTE)을 시행하였으나 최근에는 개흉술을 시행하지 않고 경열공을 통한 식도절제술(transshiatal esophagectomy, THE)도 많이 시행하고 있다. 이에 최근 본원에서 시행한 TTE와 THE의 임상 및 병리 결과를 분석하여 봄으로써 기존의 TTE에 대한 THE의 유용성에 대해 고찰해 보고자 한다. 상 및 방법: 최근 10년간 부산대학교병원에서 식도 및 위분문부암으로 진단 받고 수술적 치료를 받은 52예를 대상으로 후향적으로 자료를 수집, 분석하였다. 결과: 총 52예 중 20예에서 TTE를 32예에서 THE를 시행하였다. TTE는 중간부식도암 12예, 하부식도암 8예에서 시행되었고, THE는 중간부식도암 7예, 하부식도암 15예, 위분문부암 10예에서 시행되었다. TTE 후 식도대체장기로는 17예에서 위를, 3예에서 대장을 사용했으며, THE에서는 29예에서 위를, 3예에서 대장을 사용하였다. 술 후 합병증은 TTE를 시행한 13예(폐렴, 흉수 등 호흡기게 합병증 5예, 문합부유출 3예, 간병증 2예, 창상감염 1예, 패혈증 1예)에서, THE를 시행한 19예(문합부협착 13예, 흉수 3예, 문합부유출 1예, 창상감염 1예, 회귀후두신경마비 1예)에서 발생했다. 술 후 치료기간 동안 사망한 예는 TTE에서 1예 있었다. 수술 후 입원기간은 TTE에서 평균 25.6일, THE에서 20.6일 이었다. 결론: THE가 수술 이환율(morbidity)과 사망률(mortality)이 낮고 술식이 간편하여 시행하기가 용이하여 기존의 개흉을 통한 TTE 술식과 비교했을 때 식도절제를 요하는 대부분의 암환자들에게 유용한 술식이라 하겠다.

  • PDF

비소세포폐암 환자의 혈장 DNA를 이용한 Microsatellite 분석 (Microsatellite Alterations of Plasma DNA in Non Small Cell Lung Cancer)

  • 김규식;김은정;김수옥;오인재;박창민;정주연;김유일;임성철;박종태;김영철
    • Tuberculosis and Respiratory Diseases
    • /
    • 제58권4호
    • /
    • pp.352-358
    • /
    • 2005
  • 폐암의 조기 진단을 위한 방법으로써 MA의 의의를 알아보고자 전남대학교 병원 내과에 내원한 폐암 환자 9례(squamous cell carcinoma 6례, adenocarcinoma 2례, non-small cell lung cancer: 1례), 연령이 비슷한 비폐암 대조군 9례(AMC, 결핵: 3례, 비특이적 염증성 폐질환: 6례)와 40세 이하 정상인 12례(NC)를 대상으로, 이들의 말초혈액의 백혈구와 혈장으로부터 DNA를 추출하여 D21S1245, D3S1300, D3S1234 유전자좌의 MA를 분석하였다. 세가지 유전자좌 중 어느 한 유전자좌에서라도 MA가 관찰되면 MA가 있는 것으로 인정하였다. MA는 NC에서는 관찰되지 않았으나 0%(0/12), AMC에서는 88.9%(8/9)에서 관찰되었다. AMC와 NC 총 21례 중 흡연자에서 70%(7/10) 비흡연자에서 9.1%(1/11) MA가 관찰되었다(p<0.05). 폐암군과 AMC 총 18례 중 AMC에서 88.9%(8/9), 폐암군에서 66.7%(6/9)를 보여 양군간에 서로 차이 없이 모두 높은 빈도로 관찰되었다(p>0.05). 결과적으로 혈장 DNA의 MA는 40세 이하의 정상인들에서는 발견되지 않으며 폐암 환자들에서 높은 빈도로 발견되었다. 그러나 고령의 흡연자들인 비폐암 대조 군에서도 높은 빈도로 MA가 관찰되므로 폐암 조기진단의 지표로써는 적합하지 않을 것으로 예상된다. 그러나 본 연구는 소수의 한정된 대상을 이용한 결과로써 다양한 연령층과 흡연력 그리고 조직형에 따라 세분화된 더 큰 대상 군을 이용한 연구가 추구되어야 할 것이다.

Surgical Resection of Thoracic Duct Lymphangioma

  • Bok, Jin San;Jun, Jae Hyun;Lee, Hyun Joo;Park, In Kyu;Kang, Chang Hyun;Kim, Young Tae
    • Journal of Chest Surgery
    • /
    • 제47권4호
    • /
    • pp.423-426
    • /
    • 2014
  • A 67-year-old male patient came to the hospital due to lung cancer and mediastinal cystic mass which was suspected to be esophageal duplication cyst. Video-assisted thoracoscopic surgery (VATS) was performed and intra-operative finding suggested it as a cystic mass along the thoracic duct. Thoracic duct was ligated and the cyst was completely resected. A 48-year-old female patient visited the hospital for dysphagia. Mediastinal cystic mass was suspected to be an esophageal duplication cyst. Intraoperative finding suggest a thoracic duct lymphangioma. After thoracic duct ligation, the mass was completely resected with VATS. Postoperative chylothorax did not develop in both cases.

식도에 발생한 소세포암 -1례보고- (Small Cell Carcinoma of the Esophagus A Case Report)

  • 문현종;김영태;성숙환
    • Journal of Chest Surgery
    • /
    • 제30권2호
    • /
    • pp.241-245
    • /
    • 1997
  • 식도의 원발성 소세포암은 매우 드문 형태의 식도암이며, 위험한 예후를 동반한 극히 불량한 종양이다. 이런 악성적인 가능성으로 인하여 소세포암의 치료는 일반적으로 항암치료가 우선이다. 우리는 식도하부에 발생한 소세포암 환자 1례를 경 험하였다. 환자는 53세된 남자였으며, 진단 당시 국소적 임파절전이가 있었고, 완전 절제와 항암치료를 받았다.

  • PDF

식도 천공의 보존적 치료 - 임상적 고찰 14례 (Conservative Management of Esophageal Perforation; Clinical analysis of 14 cases)

  • 배병우;이형렬;김종원
    • Journal of Chest Surgery
    • /
    • 제26권8호
    • /
    • pp.633-637
    • /
    • 1993
  • Twenty-five patients with perforation of esophagus were managed at Pusan National University Hospital, from 1981 to 1993. The hospital course of 14 of these patients was evaluated with a special emphasis on the cause and location of perforation, clinical presentation, time elapsed from perforation to treatment, method of treatment, and outcome. Patients with anastomotic leak and cancer were excluded.The perforation was iatrogenic in 7 patients, spontaneous in 5, ingestion of foreign body in 1, and traumatic in 1. There were 7 cervical perforations, 2 upper thoracic perforations, and 5 lower thoracic perforations. Chest pain, fever, and dyspnea were frequent symptoms. Esophagography was most diagnostic [11 patients] but thoracentesis was of little diagnostic aid.Antibiotics were administered intravenously to all patients:hyperalimentation was accomplished intravenously in 11, and nasogastric suction was used in all cases. No patient required any surgical procedure, minor or major.

  • PDF

식도위 문합술후 재협착증에 대한 microwave 조직응고법적 치험 례 (An Experience of The Microwave Tissue Coagulation Therapy in The Restenosis of The Esophagogastrostomy)

  • 남충희;안욱수;이길노
    • Journal of Chest Surgery
    • /
    • 제20권4호
    • /
    • pp.859-864
    • /
    • 1987
  • The microwave tissue coagulator was originally used for hemostasis in the hepatic surgery, which is effectively applied in the endoscopic surgery such as the hemostasis of gastric ulcer or tumor bleeding, stenosis relieving of esophageal or rectal stenosis and tumor reduction in inoperable early cancer cases. We experienced the good result of the microwave tissue coagulation therapy in the patient with the restenosis of esophagogastrostomy. The patient was 67 year-old female, who was admitted due to the lye stricture of esophagus for 40 years. We made the lower esophagectomy and the esophagogastrostomy with the upper intact esophagus in the right thorax. But the restenosis occurred at the esophagogastrostomy site because of the polypoid mucosal protrusion at one month after operation. We applied the microwave tissue coagulator 3 times with 6 day interval under esophagoscopy and the good symptomatic and endoscopic relief was alleviated. We think that the microwave tissue coagulation is a very convenient and advisable method in the case of restenosis after esophageal surgery.

  • PDF

식도암의 임상적 고찰 [III] (Cancer of the Esophagus and Cardia [III]: A Clinical Review of 55 cases)

  • 이강식
    • Journal of Chest Surgery
    • /
    • 제23권5호
    • /
    • pp.922-928
    • /
    • 1990
  • Treatment of patients with esophageal carcinoma remains disappointing. Fewer than 20% *of patients with esophageal carcinoma treated with curative intent by surgery and radiation therapy will be alive at 5 years. Fifty five patients underwent treatment for carcinoma of the esophagus and cardia which retrospective clinical study done between January 1983, and December, 1989 in Department of Thoracic and Cardiovascular Surgery, National Medical Center, Seoul, Korea. There were 48 men. 7 women and the mean age was 56.2 years[range, 38 to 78 years]. The most frequent preoperative findings included dysphagia[46 cases], weight loss[33 cases] and substernal pain[19 cases]. 19 cases[34.5%] were underwent resectional surgery, which was total esophagectomy with esophagogastrostomy[ 5 cases], with colon interposition[3 cases], lower esophagectomy with esophagogastrostomy [10 cases], with total gastrectomy and esophagojejunostomy [1 case]. The operative mortality was 15.8%[3/19] and causes of death were respiratory failure in 2 cases, and 1 case of sepsis. Palliative procedures, such as feeding gastrostomy and jejunostomy[14 cases], bypass surgery without resection[ 4 cases], radiation therapy[ 3 cases] were done.

  • PDF

Current Issues in Minimally Invasive Esophagectomy

  • Na, Kwon Joong;Kang, Chang Hyun
    • Journal of Chest Surgery
    • /
    • 제53권4호
    • /
    • pp.152-159
    • /
    • 2020
  • Minimally invasive esophagectomy (MIE) was first introduced in the 1990s. Currently, it is a widely accepted surgical approach for the treatment of esophageal cancer, as it is an oncologically sound procedure; its advantages when compared to open procedures, including reduction in postoperative complications, reduction in the length of hospital stay, and improvement in quality of life, are well documented. However, debates are still ongoing about the safety and efficacy of MIE. The present review focuses on some of the current issues related to conventional MIE and robot-assisted MIE based on evidence from the current literature.

Surgical Treatment of Gastroesophageal Junction Cancer

  • Hashimoto, Tadayoshi;Kurokawa, Yukinori;Mori, Masaki;Doki, Yuichiro
    • Journal of Gastric Cancer
    • /
    • 제18권3호
    • /
    • pp.209-217
    • /
    • 2018
  • Although the incidence of gastroesophageal junction (GEJ) adenocarcinoma has been increasing worldwide, no standardized surgical strategy for its treatment has been established. This study aimed to provide an update on the surgical treatment of GEJ adenocarcinoma by reviewing previous reports and propose recommended surgical approaches. The Siewert classification is widely used for determining which surgical procedure is used, because previous studies have shown that the pattern of lymph node (LN) metastasis depends on tumor location. In terms of surgical approaches for GEJ adenocarcinoma, a consensus was reached based on two randomized controlled trials. Siewert types I and III are treated as esophageal cancer and gastric cancer, respectively. Although no consensus has been reached regarding the treatment of Siewert type II, several retrospective studies suggested that the optimal treatment strategy includes paraaortic LN dissection. Against this background, a Japanese nationwide prospective trial is being conducted to determine the proportion of LN metastasis in GEJ cancers and to identify the optimal extent of LN dissection in each type.